The high demand of GLP-1 drugs has resulted in shortages making it challenging for patients to access the medication through their regular pharmacy
Qin Y, Yu Y, Yang C, Wang Z, Yang Y, Wang C, et al
Generally, low cardiovascular risk is typically defined as the absence of cardiovascular disease and a Flemingham 10-year risk of cardiovascular events less than 20% ( Conclusion In conclusion, our meta-analysis showed that first-line use of SGLT2i and GLP-1RAs in T2DM patients at low cardiovascular disease risk significantly reduced HbA1c, body weight, and FPG levels in T2DM patients compared with placebo
Publication bias was evaluated using a funnel plot test, and sensitivity analysis was used to assess the robustness of the studies
The White Monster," suggesting both names are equally viable
Its about creating a metabolic function that feels sustainable, rather than a rollercoaster of spikes and drops